ERBB2 and breast carcinoma: Although Ano1 expression was not significantly different between HER2-positive and HER2-negative breast cancer, Ano1 expression was significantly higher in breast cancer with HER2 IHC staining of 3+ compared with breast cancer with HER2 IHC staining of 0–1+ (S6 Table).